EOC317
Product Sizes
10 mg
£ POA
HY-16025-10MG
100 mg
£ POA
HY-16025-100MG
50 mg
£ POA
HY-16025-50MG
2 mg
£ POA
HY-16025-2MG
5 mg
£ POA
HY-16025-5MG
10mM/1mL
£ POA
HY-16025-10MM
About this Product
- SKU:
- HY-16025
- Additional Names:
- ACTB-1003
- CAS Number:
- 939805-30-8
- Extra Details:
- EOC317 (ACTB-1003) is an oral kinase inhibitor with IC50s of 6; 2 and 4 nM for FGFR1; VEGFR2 and Tie-2.
- Molecular Weight:
- 591.53
- Purity:
- 98.01
- References:
- [1]Patel K, et al. ACTB-1003: An oral kinase inhibitor targeting cancer mutations (FGFR), angiogenesis (VEGFR2, TEK), and induction of apoptosis (RSK and p70S6K). Journal of Clinical Oncology 28, no. 15 DOI: 10.1200/jco.2010.28.15_suppl.e13665
- Research Area:
- Cancer
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Protein Tyrosine Kinase/RTK
